Skip to content

Clinical trials

Phase 2/3 Coronary Artery Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 2/3 Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20032
20045
20051
20062
20071
20086
20095
20102
20114
20121
20134
20141
20152
20161
20172
20192
20201
20212
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Unknown status14
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital of Harbin Medical University4
Shanghai Jiao Tong University School of Medicine3
Taichung Veterans General Hospital3
Boston Scientific Corporation2
Cordis US Corp.2
Ottawa Heart Institute Research Corporation2
Shahid Beheshti University of Medical Sciences2
UMC Utrecht2
University of Sao Paulo General Hospital2
AHEPA University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease54
Atherosclerosis7
Diabetes Mellitus4
Heart Failure4
Myocardial Ischemia4
Acute Coronary Syndrome3
Angina, Stable3
Coronary Disease3
Heart Diseases3
Inflammation3

Trials

Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.